Top

Published in:

01-11-2019 | Diabetes | Original Article

Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome

Authors: Maryam Sobhani, Mohammad Amin Tabatabaiefar, Soudeh Ghafouri-Fard, Asadollah Rajab, Sarah Mozafarpour, Samaneh Nasrniya, Abdol-Mohammad Kajbafzadeh, Mohammad Reza Noori-Daloii

Published in: Endocrine | Issue 2/2019

Abstract

Purpose

Wolfram syndrome (WS) is a rare genetic disorder described by a pattern of clinical manifestations such as diabetes mellitus, diabetes insipidus, optic nerve atrophy, sensorineural hearing loss, urinary tract abnormalities, and psychiatric disorders. WFS1 and WFS2 loci are the main genetic loci associated with this disorder.

Methods

In the current study, we investigated associations between these loci and WS via STR markers and homozygosity mapping in 13 Iranian families with WS. All families were linked to WFS1 locus.

Results

Mutation analysis revealed four novel mutations (Q215X, E89X, S168Del, and E391Sfs*51) in the assessed families. Bioinformatics tools confirmed the pathogenicity of the novel mutations. Other identified mutations were previously reported in other populations for their pathogenicity.

Conclusions

The current study adds to the mutation repository of WS and shows a panel of mutations in Iranian population. Such panel would facilitate genetic counseling and prenatal diagnosis in families with WS cases.

T. Hershey, H.M. Lugar, J.S. Shimony, J. Rutlin, J.M. Koller, D.C. Perantie, A.R. Paciorkowski, S.A. Eisenstein, M.A. Permutt, Washington University Wolfram Study, G.: early brain vulnerability in Wolfram syndrome. PloS ONE 7(7), e40604 (2012). https://doi.org/10.1371/journal.pone.0040604 CrossRefPubMedPubMedCentral

R.G. Swift, D.B. Sadler, M. Swift, Psychiatric findings in Wolfram syndrome homozygotes. Lancet 336(8716), 667–669 (1990)CrossRef

S. Mozafarpour, A.M. Kajbafzadeh, A. Mojtahed, M. Mojtahed, H. Mahboubi, K. Shalileh, Management of bladder dysfunction in Wolfram syndrome with Mitrofanoff appendicovesicostomy: long-term follow-up. J. Pediatr. Surg. (2014). https://doi.org/10.1016/j.jpedsurg.2014.09.058 CrossRef

M. Sobhani, M.A. Tabatabaiefar, A. Rajab, A.M. Kajbafzadeh, M.R. Noori-Daloii, Significant expressivity of Wolfram syndrome: phenotypic assessment of two known and one novel mutation in the WFS1 gene in three Iranian families. Mol. Biol. Rep. 41(11), 7499–7505 (2014). https://doi.org/10.1007/s11033-014-3642-3 CrossRefPubMed

H. Inoue, Y. Tanizawa, J. Wasson, P. Behn, K. Kalidas, E. Bernal-Mizrachi, M. Mueckler, H. Marshall, H. Donis-Keller, P. Crock, D. Rogers, M. Mikuni, H. Kumashiro, K. Higashi, G. Sobue, Y. Oka, M.A. Permutt, A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat. Genet. 20(2), 143–148 (1998). https://doi.org/10.1038/2441 CrossRefPubMed

T.M. Strom, K. Hortnagel, S. Hofmann, F. Gekeler, C. Scharfe, W. Rabl, K.D. Gerbitz, T. Meitinger, Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet 7(13), 2021–2028 (1998). https://doi.org/10.1093/hmg/7.13.2021 CrossRefPubMed

G. Boutzios, S. Livadas, E. Marinakis, N. Opie, F. Economou, E. Diamanti-Kandarakis, Endocrine and metabolic aspects of the Wolfram syndrome. Endocrine 40(1), 10–13 (2011). https://doi.org/10.1007/s12020-011-9505-y CrossRefPubMed

J. Kawano, R. Fujinaga, K. Yamamoto-Hanada, Y. Oka, Y. Tanizawa, K. Shinoda, Wolfram syndrome 1 (Wfs1) mRNA expression in the normal mouse brain during postnatal development. Neurosci. Res. 64(2), 213–230 (2009). https://doi.org/10.1016/j.neures.2009.03.005 CrossRefPubMed

J. Grenier, I. Meunier, V. Daien, C. Baudoin, F. Halloy, B. Bocquet, C. Blanchet, C. Delettre, E. Esmenjaud, A. Roubertie, G. Lenaers, C.P. Hamel, WFS1 in optic neuropathies: mutation findings in nonsyndromic optic atrophy and assessment of clinical severity. Ophthalmology 123(9), 1989–1998 (2016). https://doi.org/10.1016/j.ophtha.2016.05.036 CrossRefPubMed

10.

M. Sobhani, M.A. Tabatabaiefar, A. Rajab, A.M. Kajbafzadeh, M.R. Noori-Daloii, Molecular characterization of WFS1 in an Iranian family with Wolfram syndrome reveals a novel frameshift mutation associated with early symptoms. Gene 528(2), 309–313 (2013). https://doi.org/10.1016/j.gene.2013.06.040 CrossRefPubMed

11.

T.G. Barrett, M. Scott-Brown, A. Seller, A. Bednarz, K. Poulton, J. Poulton, The mitochondrial genome in Wolfram syndrome. J. Med. Genet. 37(6), 463–466 (2000)CrossRef

12.

Y. Noguchi, T. Yashima, A. Hatanaka, M. Uzawa, M. Yasunami, A. Kimura, K. Kitamura, A mutation in Wolfram syndrome type 1 gene in a Japanese family with autosomal dominant low-frequency sensorineural hearing loss. Acta Otoaryngol. 125(11), 1189–1194 (2005)CrossRef

13.

K.A. Pickett, R.P. Duncan, A.R. Paciorkowski, M.A. Permutt, B. Marshall, T. Hershey, G.M. Earhart; Washington University Wolfram Study, G., Balance impairment in individuals with Wolfram syndrome. Gait posture 36(3), 619–624 (2012). https://doi.org/10.1016/j.gaitpost.2012.06.008 CrossRefPubMedPubMedCentral

14.

T. Barrett, S. Bundey, A. Macleod, Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346(8988), 1458–1463 (1995)CrossRef

15.

M. Saadat, M. Ansari-Lari, D.D. Farhud, Consanguineous marriage in Iran. Ann. Hum. Biol. 31(2), 263–269 (2004). https://doi.org/10.1080/03014460310001652211 CrossRefPubMed

16.

S. Ari, U. Keklikci, I. Caca, K. Unlu, H. Kayabasi, Wolfram syndrome: case report and review of the literature. Compr. Ther. 33(1), 18–20 (2007)CrossRef

17.

M. Al-Till, N.S. Jarrah, K.M. Ajlouni, Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur. J. Ophthalmol. 12(2), 84–88 (2002)CrossRef

18.

A. Cano, L. Molines, R. Valero, G. Simonin, V. Paquis-Flucklinger, B. Vialettes; French Group of Wolfram, S., Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and duration-matched comparison with common type 1 diabetes. Diabetes Care 30(9), 2327–2330 (2007). https://doi.org/10.2337/dc07-0380 CrossRefPubMed

19.

J. Rohayem, C. Ehlers, B. Wiedemann, R. Holl, K. Oexle, O. Kordonouri, G. Salzano, T. Meissner, W. Burger, E. Schober, A. Huebner, M.A. Lee-Kirsch, Wolfram syndrome diabetes writing, G.: diabetes and neurodegeneration in Wolfram syndrome: a multicenter study of phenotype and genotype. Diabetes Care 34(7), 1503–1510 (2011). https://doi.org/10.2337/dc10-1937 CrossRefPubMedPubMedCentral

20.

A. Colosimo, V. Guida, L. Rigoli, C. Di Bella, A. De Luca, S. Briuglia, L. Stuppia, D.C. Salpietro, B. Dallapiccola, Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum. Mutat. 21(6), 622–629 (2003). https://doi.org/10.1002/humu.10215 CrossRefPubMed

21.

J.M. van ven Ouweland, K. Cryns, R.J. Pennings, I. Walraven, G.M. Janssen, J.A. Maassen, B.F. Veldhuijzen, A.B. Arntzenius, D. Lindhout, C.W. Cremers, G. Van Camp, L.D. Dikkeschei, Molecular characterization of WFS1 in patients with Wolfram syndrome. J. Mol. Diagn. 5(2), 88–95 (2003)CrossRef

22.

23.

C.J. Smith, P.A. Crock, B.R. King, C.J. Meldrum, R.J. Scott, Phenotype-genotype correlations in a series of wolfram syndrome families. Diabetes Care 27(8), 2003–2009 (2004)CrossRef

24.

F.M. Elli, S. Ghirardello, C. Giavoli, S. Gangi, L. Dioni, M. Crippa, P. Finelli, S. Bergamaschi, F. Mosca, A. Spada, P. Beck-Peccoz, A new structural rearrangement associated to Wolfram syndrome in a child with a partial phenotype. Gene 509(1), 168–172 (2012). https://doi.org/10.1016/j.gene.2012.06.077 CrossRefPubMed

25.

S.A. Yuca, N.D. Rendtorff, H. Boulahbel, M. Lodahl, L. Tranebjaerg, Y. Cesur, M. Dogan, C. Yilmaz, C. Akgun, M. Acikgoz, Rapidly progressive renal disease as part of Wolfram syndrome in a large inbred Turkish family due to a novel WFS1 mutation (p.Leu511Pro). Eur. J. Med. Genet. 55(1), 37–42 (2012). https://doi.org/10.1016/j.ejmg.2011.08.005 CrossRefPubMed

26.

Aloi, C., Salina, A., Pasquali, L., Lugani, F., Perri, K., Russo, C., Tallone, R., Ghiggeri, G. M., Lorini, R., d’Annunzio, G., Wolfram syndrome: new mutations, different phenotype. PloS ONE 7(1) (2012). https://doi.org/10.1371/journal.pone.0029150 CrossRef

27.

M.A. Ganie, B.A. Laway, S. Nisar, M.M. Wani, M.L. Khurana, F. Ahmad, S. Ahmed, P. Gupta, I. Ali, I. Shabir, A. Shadan, A. Ahmed, S. Tufail, Presentation and clinical course of Wolfram (DIDMOAD) syndrome from North India. Diabet. Med. 28(11), 1337–1342 (2011). https://doi.org/10.1111/j.1464-5491.2011.03377.x CrossRefPubMed

28.

G. Yu, M.L. Yu, J.F. Wang, C.R. Gao, Z.J. Chen, WS1 gene mutation analysis of Wolfram syndrome in a Chinese patient and a systematic review of literatures. Endocrine 38(2), 147–152 (2010). https://doi.org/10.1007/s12020-010-9350-4 CrossRefPubMed

29.

A. Zmyslowska, M. Borowiec, K. Antosik, M. Szalecki, A. Stefanski, B. Iwaniszewska, M. Jedrzejczyk, I. Pietrzak, W. Mlynarski, Wolfram syndrome in the Polish population: novel mutations and genotype-phenotype correlation. Clin. Endocrinol. 75(5), 636–641 (2011). https://doi.org/10.1111/j.1365-2265.2011.04102.x CrossRef

30.

M.U. Aluclu, M. Bahceci, A. Tuzcu, S. Arikan, D. Gokalp, A new mutation in WFS1 gene (C.1522-1523delTA, Y508fsX421) may be responsible for early appearance of clinical features of Wolfram syndrome and suicidal behaviour. Neuro Endocrinol. Lett. 27(6), 691–694 (2006)PubMed

31.

F. Giuliano, S. Bannwarth, S. Monnot, A. Cano, B. Chabrol, B. Vialettes, B. Delobel, V. Paquis-Flucklinger, French Group of, W.S.: Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum. Mutat. 25(1), 99–100 (2005). https://doi.org/10.1002/humu.9300 CrossRefPubMed

32.

E. Domenech, M. Gomez-Zaera, V. Nunes, Study of the WFS1 gene and mitochondrial DNA in Spanish Wolfram syndrome families. Clin. Genet. 65(6), 463–469 (2004). https://doi.org/10.1111/j.1399-0004.2004.00249.x CrossRefPubMed

33.

P. Zalloua, S.T. Azar, M. Delepine, N.J. Makhoul, H. Blanc, M. Sanyoura, A. Lavergne, K. Stankov, A. Lemainque, P. Baz, C. Julier, WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon. Hum. Mol. Genet. 17(24), 4012–4021 (2008). https://doi.org/10.1093/hmg/ddn304 CrossRefPubMed

34.

J.C. Zenteno, G. Ruiz, H.J. Perez-Cano, M. Camargo, Familial Wolfram syndrome due to compound heterozygosity for two novel WFS1 mutations. Mol. Vis. 14(163), 1353–1357 (2008)PubMedPubMedCentral

35.

M.R. Gasparin, F. Crispim, S.L. Paula, M.B. Freire, I.S. Dalbosco, T.D. Manna, J.E. Salles, F. Gasparin, A. Guedes, J.M. Marcantonio, M. Gambini, C.P. Salim, R.S. Moises, Identification of novel mutations of the WFS1 gene in Brazilian patients with Wolfram syndrome. Eur. J. Endocrinol. 160(2), 309–316 (2009). https://doi.org/10.1530/EJE-08-0698 CrossRefPubMed

36.

C. Hardy, F. Khanim, R. Torres, M. Scott-Brown, A. Seller, J. Poulton, D. Collier, J. Kirk, M. Polymeropoulos, F. Latif, T. Barrett, Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am. J. Hum. Genet. 65(5), 1279–1290 (1999). https://doi.org/10.1086/302609 CrossRefPubMedPubMedCentral

Title: Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome
Authors: Maryam Sobhani
Mohammad Amin Tabatabaiefar
Soudeh Ghafouri-Fard
Asadollah Rajab
Sarah Mozafarpour
Samaneh Nasrniya
Abdol-Mohammad Kajbafzadeh
Mohammad Reza Noori-Daloii
Publication date: 01-11-2019
Publisher: Springer US
Keyword: Diabetes
Published in: Endocrine / Issue 2/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-019-02004-w

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome

Abstract

Purpose

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2019

A transgenic mouse that spontaneously develops pathogenic TSH receptor antibodies will facilitate study of antigen-specific immunotherapy for human Graves’ disease

Hypothyroidism-related zinc deficiency leads to suppression of T lymphocyte activity

Trabecular bone score: a useful clinical tool for the evaluation of skeletal health in women of short stature

Author Response to “In Defense of the UVB-Vitamin D-Cancer Hypothesis.”

Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways

Testosterone levels after treatment with urofollitropin in infertile patients with idiopathic mild reduction of testicular volume

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page